Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D 2

Oncology Reports

Volumn 28, Issue 3, 2012, Pages 1110-1116

  Baurska, Hanna ^a   Marchwicka, Aleksandra ^a   Kłopot, Anna ^a   Kutner, Andrzej ^b   Marcinkowska, Ewa ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

1,25 dihydroxy vitamin D 3; Acute myeloid leukemia; Analogs; C EBP ; Chromatin; CYP24A1; Differentiation; Nucleosol; Vitamin D receptor

Indexed keywords

1 AMINOBENZOTRIAZOLE; CALCITRIOL; CCAAT ENHANCER BINDING PROTEIN BETA; CD11B ANTIGEN; CD14 ANTIGEN; CYTOCHROME P450 2A1; KETOCONAZOLE; MESSENGER RNA; PRI 1906; PRI 1907; PROADIFEN; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ACUTE LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME DEGRADATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ANTIGENS, CD14; ANTINEOPLASTIC AGENTS; CALCITRIOL; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; ERGOCALCIFEROLS; GENE EXPRESSION; HL-60 CELLS; HUMANS; KETOCONAZOLE; KINETICS; MITOCHONDRIA; PROTEIN TRANSPORT; RECEPTORS, CALCITRIOL; RETINOID X RECEPTORS; STEROID HYDROXYLASES; UP-REGULATION;

EID: 84865309296     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1886     Document Type: Article

References (27)

1. 3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal bone marrow cells. Leuk Res 7: 51-55, 1983.
2. 3. Proc Natl Acad Sci USA 78: 4990-4994, 1981.
3. 3: basic concepts. J Steroid Biochem Mol Biol 97: 93-101, 2005.
4. Brown A and Slatopolsky E: Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol Aspects Med 29: 433-452, 2008.
5. Rachez C, Lemon B, Suldan Z, Bromleigh V, Gamble M, Naar A, Erdjument-Bromage H, Tempst P and Freedman L: Liganddependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398: 824-828, 1999.
6. Aranda A and Pascual A: Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269-1304, 2001.
7. Mizwicki M and Norman A: Vitamin D sterol/VDR conformational dynamics and non-genomic actions. In: Vitamin D. Feldman D, Pike J and Adams J (eds). 3rd edition. Academic Press, London, pp271-297, 2011.
8. 2 analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation. J Steroid Biochem Mol Biol 126: 46-54, 2011.
9. 3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells. Cell Cycle 1: 410-415, 2002.
10. Wietrzyk J, Nevozhay D, Milczarek M, Filip B and Kutner A: Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer Chemother Pharmacol 62: 787-797, 2008.
11. Brown AJ: Mechanisms for the selective actions of vitamin D analogs. In: Vitamin D. Feldman D, Pike JW and Adams JS (eds). 3rd edition. Academic Press, London, pp1436-1459, 2011.
12. Chow CW, Grinstein S and Rotstein OD: Signaling events in monocytes and macrophages. New Horiz 3: 342-351, 1995.
13. Kahlen J and Carlberg C: Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter. Biochem Biophys Res Commun 202: 1366-1372, 1994.
14. Muindi JR, Yu WD, Ma Y, Engler KL, Kong RX, Trump DL and Johnson CS: CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology 151: 4301-4312, 2010.
15. 3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells. J Steroid Biochem Mol Biol 98: 228-235, 2006.
16. Peehl DM, Seto E, Hsu JY and Feldman D: Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells. J Urol 168: 1583-1588, 2002.
17. 3-induced differentiation of HL60 cells. Cancer Res 64: 370-377, 2004.
18. 3. Exp Cell Res 312: 2054-2065, 2006.
19. Ramji D and Foka P: CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575, 2002.
20. Wiedlocha A, Nilsen T, Wesche J, Sorensen V, Malecki J, Marcinkowska E and Olsnes S: Phosphorylation-regulated nucleocytoplasmic trafficking of internalized fibroblast growth factor-1. Mol Biol Cell 16: 794-810, 2005.
21. 3 structure that produce profound changes in in vivo activity. In: Vitamin D. Feldman D, Pike JW and Adams JS (eds). 3rd edition. Academic Press, London, pp1429-1435, 2011.
22. 2. (24E)-(1S)-24-Dehydro-24ahomo- 1,25-dihydroxyergocalciferol and congeners. Steroids 67: 789-798, 2002.
23. Marcinkowska E, Wiedlocha A and Radzikowski C: Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol. Anticancer Res 18: 3507-3514, 1998.
24. Marcinkowska E, Wang X and Studzinski G: C/EBPβ: a candidate for a major player in vitamin D-induced monocytic differentiation of human leukemia cells. In: Vitamin D: New Research. Stolzt V (ed). Nova Science Publishers, Inc., New York, NY, pp25-40, 2006.
25. Gocek E, Kielbinski M, Wylob P, Kutner A and Marcinkowska E: Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential. Steroids 73: 1359-1366, 2008.
26. Gocek E, Kielbinski M and Marcinkowska E: Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation. FEBS Lett 581: 1751-1757, 2007.
27. Gutsch R, Kandemir J, Pietsch D, Cappello C, Meyer J, Simanowski K, Huber R and Brand K: CCAAT/enhancer-binding protein β inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology. J Biol Chem 286: 22716-22729, 2011.